Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -38.21% is 27% below its 5-year average of -30.04%, near the high end of its 5-year range (-82.16%–-19.83%).
As of the fiscal period ended Tuesday, June 30, 2026. 15.33% below its 12-month average of -33.13%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -38.21%.
RETURN ON INVESTED CAPITAL (ROIC)
-38.21%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-33.13%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-27.69%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-30.04%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-15.33%
CURRENT VS 3Y AVG
-37.98%
CURRENT VS 5Y AVG
-27.18%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.61%
median of 660 covered companies
CURRENT VS SECTOR MEDIAN
-13.67%
vs the sector median at left
Disc Medicine, Inc.
Market Cap
$2.47B
Return on Invested Capital (ROIC)
-38.21%
TTM Avg
-33.13%
3Y Avg
-27.69%
5Y Avg
-30.04%
Market Cap
$2.42B
Return on Invested Capital (ROIC)
-26.95%
TTM Avg
-26.95%
3Y Avg
-26.95%
5Y Avg
-26.95%
Market Cap
$2.43B
Return on Invested Capital (ROIC)
-49.78%
TTM Avg
-43.13%
3Y Avg
-47.40%
5Y Avg
-42.10%
Market Cap
$2.41B
Return on Invested Capital (ROIC)
-4.62%
TTM Avg
-19.11%
3Y Avg
-45.14%
5Y Avg
-60.93%
Market Cap
$2.38B
Return on Invested Capital (ROIC)
27.60%
TTM Avg
29.86%
3Y Avg
13.68%
5Y Avg
-0.60%
Market Cap
$2.38B
Return on Invested Capital (ROIC)
-77.92%
TTM Avg
-42.31%
3Y Avg
-48.27%
5Y Avg
-40.00%
Market Cap
$2.36B
Return on Invested Capital (ROIC)
46.99%
TTM Avg
-39.61%
3Y Avg
-45.77%
5Y Avg
-48.25%
Market Cap
$2.59B
Return on Invested Capital (ROIC)
0.00%
TTM Avg
2.20%
3Y Avg
0.80%
5Y Avg
-4.44%
Market Cap
$2.64B
Return on Invested Capital (ROIC)
-38.70%
TTM Avg
-28.14%
3Y Avg
-29.66%
5Y Avg
-30.84%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Disc Medicine, Inc. (IRON) | $2.47B | -38.21% | -33.13% | -27.69% | -30.04% |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.42B | -26.95% | -26.95% | -26.95% | -26.95% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.43B | -49.78% | -43.13% | -47.40% | -42.10% |
| Clover Health Investments, Corp. (CLOV)vs › | $2.41B | -4.62% | -19.11% | -45.14% | -60.93% |
| ADMA Biologics, Inc. (ADMA)vs › | $2.38B | 27.60% | 29.86% | 13.68% | -0.60% |
| Nurix Therapeutics, Inc. (NRIX)vs › | $2.38B | -77.92% | -42.31% | -48.27% | -40.00% |
| Liquidia Corporation (LQDA)vs › | $2.36B | 46.99% | -39.61% | -45.77% | -48.25% |
| Privia Health Group, Inc. (PRVA)vs › | $2.59B | 0.00% | 2.20% | 0.80% | -4.44% |
| NewAmsterdam Pharma Company N.V. (NAMS)vs › | $2.64B | -38.70% | -28.14% | -29.66% | -30.84% |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.32B | 14.96% | 15.56% | 18.20% | 16.63% |
ROIC
-38.2%
ROE
-38.2%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -38.21% |
| 2026-03-31 | -36.92% |
| 2025-12-31 | -30.62% |
| 2025-09-30 | -33.73% |
| 2025-06-30 | -26.19% |
| 2025-03-31 | -20.01% |
| 2024-12-31 | -27.40% |
| 2024-09-30 | -26.59% |
| 2024-06-30 | -22.65% |
| 2024-03-31 | -28.72% |
| 2023-12-31 | -26.29% |
| 2023-09-30 | -22.83% |
| 2023-06-30 | -19.83% |
| 2023-03-31 | -29.49% |
| 2022-12-31 | -30.28% |
| 2022-09-30 | -48.00% |
| 2022-06-30 | -52.97% |
| 2022-03-31 | -53.96% |
| 2021-12-31 | -82.16% |
| 2021-09-30 | -29.84% |
| 2021-06-30 | -20.27% |
| 2021-03-31 | -13.27% |
